ATXS vs EPAM · rev $706.0K vs P/E 14, rev $2.81B
Astria Therapeutics Inc (ATXS) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ATXS currently screens at market cap $382.1M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ATXS and EPAM stock pages for the full models.
Not investment advice.